1 paper
Michael Shapiro, Herut Dor, Anna Gurevich-Shapiro +2
Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but can result in severe immune-related adverse events (IrAEs). Monitoring IrAEs on a large sca…